Compugen Stock

Compugen Working Capital

The Working Capital of Compugen (CGEN) as of Sep 4, 2026 is 126.88 M USD. In the previous year, Working Capital was 86.78 M USD — a change of 46.21% (higher).

Working Capital

126.88 MUSD

YoY

46.21%

Last updated:

Working Capital of Compugen is 2026 126.88 M USD. Working Capital of Compugen was 2025 86.78 M USD. It decreases by 46.21% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Working Capital of Compugen is 126.88 M USD in 2026.

Working Capital of Compugen changed from 86.78 M USD to 126.88 M USD, representing a 46.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Compugen since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Compugen historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Compugen

All Key Metrics — Compugen